临床研究
Copyright ©The Author(s) 2007.
世界华人消化杂志. 2007-10-28; 15(30): 3194-3203
在线出版 2007-10-28. doi: 10.11569/wcjd.v15.i30.3194
表1 220例胃癌患者MSCT与病理T分期的对照
病理分期nMSCT分期
T1T2T3T4准确率(%)
T1473755078.72
T22951211141.38
T3962581884.38
T4480054389.58
表2 193例胃癌患者MSCT与病理N分期的对照
病理分期nMSCT分期
N0N1N2准确率(%)
N0765613773.68
N1601541468.33
N257294680.70
表3 205例胃癌患者MSCT与病理TNM分期的对照
病理分期nMSCT分期
ⅠaⅠbⅢaⅢb
Ⅰa392783010
Ⅰb20765200
29278750
Ⅲa411152482
Ⅲb350026225
410003533
表4 胃癌患者血清肿瘤标志物水平与其临床病理特征的关系
临床病理因素nCA125 (kU/L)PCA19-9 (kU/L)PCA72-4 (kU/L)PCEA (mg/L)PAFP(mg/L)P
年龄(岁)0.5310.3010.3820.1620.813
<6112515.52±20.92143.83±574.8212.92±46.553.81±8.694.49±12.84
≥619517.34±21.74285.39±1378.588.49±18.6434.82±214.414.16±4.84
性别0.5210.3140.3320.2810.583
女性7717.57±24.35323.96±1536.6014.81±47.943.16±9.683.84±4.01
男性14315.63±19.43140.88±527.928.96±29.7924.76±175.074.63±12.28
肿瘤部位0.9500.1350.2180.7140.590
下1/314316.10±22.00120.10±510.798.89±27.4922.93±174.854.82±12.41
中1/35717.06±22.58433.31±1776.1818.24±58.277.53±22.253.76±3.45
上1/32015.66±8.93160.91±393.365.54±6.273.83±4.062.65±1.15
肿瘤最大径(cm)0.0040.0180.0010.8750.118
<512112.44±15.4645.25±264.563.00±4.6118.57±177.923.28±1.86
≥59921.03±25.98400.16±1447.8720.79±53.7015.53±77.175.66±1.96
组织学类型0.0160.4840.0570.4030.724
分化型8112.62±9.40142.67±499.706.10±10.186.72±19.154.03±5.38
未分化型13918.46±25.54241.26±1204.5413.87±45.9223.3±177.324.54±12.14
浸润深度0.0000.0050.0010.1160.245
T1/2769.92±7.3714.16±55.302.68±4.542.16±2.703.25±2.03
T3/414419.68±20.09305.66±1229.7115.40±45.2525.14±174.534.93±12.46
淋巴结转移0.0060.0880.0130.0970.287
N07610.69±8.5767.99±499.433.00±5.832.06±2.393.45±3.24
N1/211715.52±13.52295.88±1294.1312.31±39.1513.06±71.095.19±13.65
远处转移0.0080.2490.0640.1780.992
M018813.09±11.51172.73±990.047.39±25.674.26±12.794.35±10.75
M13235.22±44.25394.31±1078.5332.23±72.3593.25±365.254.33±5.85
肝脏转移0.3090.6640.8000.3950.752
21416.06±21.21209.89±1017.4610.90±37.5614.04±134.304.39±10.31
625.03±22.4729.05±28.4414.80±18.84129.75±304.253.05±0.77
腹膜转移0.0190.2570.0920.7570.732
20213.56±11.89173.54±963.727.78±25.2118.08±147.554.42±10.60
1847.16±55.20557.54±1362.9847.24±93.587.28±16.603.56±2.03
远处淋巴结转移0.5230.4250.0960.1910.675
20616.07±21.67190.83±1006.777.87±25.064.48±13.124.27±10.29
1419.82±14.84412.84±971.4357.84±104.08204.43±542.315.46±8.58
TNM分期0.0040.0320.0300.1270.165
Ⅰa-Ⅲa12912.22±12.2956.03±387.875.34±23.532.30±2.733.42±2.64
Ⅲb, Ⅳ7623.33±30.93462.35±1598.1419.01±50.8344.61±239.256.16±16.88
可切除性0.0250.9630.1400.3500.550
2735.54±47.90196.54±452.5327.92±64.8377.76±376.093.25±1.65
19313.62±12.03206.14±1059.128.64±30.988.73±55.544.50±10.84
表5 胃癌患者血清肿瘤标志物水平与其临床病理特征的关系
临床病理 因素nCA125 (kU/L)
PCA19-9 (kU/L)
PCA72-4 (kU/L)
PCEA (mg/L)
PAFP (mg/L)
P
-+-+-+-+-+
年龄(岁)0.4110.2680.480.3981.000
<61125118710025953011781223
≥619587870257619869923
性别0.6740.3990.2850.0371.000
女性7771662156314752752
男性14313491083510835128151394
肿瘤部位0.3270.9230.6810.6240.582
下1/3143131121103311231133101385
中1/35754345124512516561
上1/320200155146191200
肿瘤最大径(cm)0.0810.00000.0270.093
<51211165106151071411651201
≥5998910643564358712945
组织学类型0.1620.5960.3070.0180.672
分化型8178361206615756783
未分化型139127121093010534128111363
浸润深度0.0730.00000.0400.667
T1/276742724715742751
T3/414413113984610044129151395
淋巴结转移0.4870.0000.0020.0671.000
N076742724697742742
N1/2117110786318532106111134
远处转移0.0020.0020.0020.0051.000
M018818081523615335178101835
M13225718141814257311
肝脏转移0.3490.6210.6170.0701.000
214200141664816747199152086
65142424260
腹膜转移0.0000.0360.0010.6361.000
20219391604216339187151966
18126108810162180
远处淋巴结转移1.0000.0930.0170.0020.329
206192141624416442194122015
14131867795131
TNM分期0.1070.00000.0000.197
Ⅰa-Ⅲa1291236116131141512631272
Ⅲb, Ⅳ76688482847296412724
可切除性0.0050.0000.0490.1391.000
2721612151710234270
19318491583515439180131876

引文著录: 严超, 朱正纲, 燕敏, 陈克敏, 陈军, 刘炳亚, 尹浩然, 林言箴. 多层螺旋CT和血清肿瘤标志物对胃癌术前评估的价值. 世界华人消化杂志 2007; 15(30): 3194-3203